Article
The m6A Methylation Gene SNRPC can be used as a Biomarker for the Prognosis and Immunotherapy of Hepatocellular Carcinoma
2021-03-22
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. Due to its complex pathogenic factors, the prognosis of HCC is poor. Therefore, a credible prognostic biomarker is urgently needed for this disease. N6-methyladenosine (m<sup>6</sup>A) RNA methylation plays an important role in the tumorigenesis, progression and prognosis of many...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 586f6e5f-26d7-5056-a307-9f804b84c2ae
- DOI
- 10.21203/rs.3.rs-320369/v1
